论文信息 - Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study - 字舞流文

Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study

M. Lai | J. Yeon | T. Chen | Y. Chao | S. Um | M. Cho | Ting Chang | K. Han | C. Peng | E. Teo | J. Sullivan-Bolyai | T. Huo | W. Chuang | K. Hu | C. M. Lee | S. Hwang | S. Lim | S. Yang | Y. Xu | T. Nguyen | K. S. Lee | H. Lin